Vertex EVP Joy Liu files initial ownership report

Vertex Pharmaceuticals executive Joy Liu has filed an initial ownership report outlining her equity holdings in the company.

Rhea-AI Filing Summary

Vertex Pharmaceuticals executive Joy Liu has filed an initial ownership report outlining her equity holdings in the company. As EVP and Chief Legal Officer, she reports direct ownership of 23,703 shares of common stock.

She also reports two grants of stock options (rights to buy shares) covering 7,044 and 5,363 shares, with a footnote indicating that at least one of these option awards is fully vested. The filing does not reflect new purchases or sales but establishes her baseline ownership position.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Liu Joy

Role EVP and Chief Legal Officer

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 12,407 contracts (Direct); Common Stock — 23,703 shares (Direct)

Footnotes (1)

1. F1. Fully vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Joy Liu’s Form 3 filing show for VRTX?

The Form 3 shows that Joy Liu, EVP and Chief Legal Officer, reports direct ownership of 23,703 shares of Vertex common stock plus two stock option awards, one of which is noted as fully vested, establishing her initial reported equity position in the company.

Did Joy Liu buy or sell VRTX shares in this Form 3?

The Form 3 does not report any new purchases or sales of Vertex shares. It serves as an initial ownership statement, listing Joy Liu’s existing common stock and stock option holdings as of the reported date without recording trading activity.

How many Vertex common shares does Joy Liu report owning?

Joy Liu reports direct ownership of 23,703 shares of Vertex Pharmaceuticals common stock. This figure represents her baseline equity stake disclosed in the Form 3 filing and does not indicate any change from a prior reported position.

What stock options are reported for Joy Liu at Vertex (VRTX)?

She reports two stock option positions described as “Stock Option (Right to Buy)” covering 7,044 and 5,363 shares, respectively. A footnote states that one of these option awards is fully vested, indicating it is currently exercisable under its terms.

What is the significance of the ‘fully vested’ footnote in Joy Liu’s filing?

The ‘fully vested’ footnote means at least one reported stock option grant is no longer subject to vesting conditions and can be exercised under its terms. This clarifies that part of Joy Liu’s option-based compensation is immediately exercisable for Vertex shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 04:41 PM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Liu Joy

(Last) (First) (Middle)

C/O VERTEX PHARMACEUTICALS INCORPORATED

50 NORTHERN AVENUE

(Street)

BOSTON MA 02210

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/01/2026

3. Issuer Name and Ticker or Trading Symbol
VERTEX PHARMACEUTICALS INC / MA [ VRTX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Chief Legal Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	23,703	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	02/05/2028	Common Stock	7,044	$155.57	D
Stock Option (Right to Buy)	(1)	02/05/2029	Common Stock	5,363	$187.53	D

Explanation of Responses:

1. Fully vested.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Christiana Stevenson, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.